JBIOVSLABT• 3 Months (Normalized)
JBIO vs LABT (Jade Biosciences Inc. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Jun, 19 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
JBIO Performance $17.14
-11.88%
Jade Biosciences Inc.
Normalized Baseline0.00%
LABT Performance $1.86
-49.04%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin JBIO LEADS
+37.16%
JBIO outperforming by 37.16%
JBIOLABT
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
JBIO LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | JBIO Price | JBIO Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $17.14 | -11.88% | $1.86 | -49.04% | +37.16% |
| Sep 16, 2026 | $16.65 | -14.40% | $2.09 | -42.74% | +28.34% |
| Sep 15, 2026 | $17.38 | -10.64% | $2.17 | -40.55% | +29.91% |
| Sep 14, 2026 | $18.18 | -6.53% | $2.12 | -41.92% | +35.39% |
| Sep 11, 2026 | $17.89 | -8.02% | $2.22 | -39.18% | +31.16% |
| Sep 10, 2026 | $19.14 | -1.59% | $2.05 | -43.84% | +42.25% |
| Sep 09, 2026 | $19.06 | -2.01% | $2.32 | -36.44% | +34.43% |
| Sep 08, 2026 | $19.45 | +0.00% | $2.18 | -40.27% | +40.27% |
| Sep 04, 2026 | $19.90 | +2.31% | $1.88 | -48.49% | +50.80% |
| Sep 03, 2026 | $19.85 | +2.06% | $1.90 | -47.95% | +50.01% |
| Sep 02, 2026 | $21.40 | +10.03% | $2.07 | -43.29% | +53.32% |
| Sep 01, 2026 | $21.02 | +8.07% | $2.76 | -24.38% | +32.45% |
| Aug 31, 2026 | $21.36 | +9.82% | $2.50 | -31.51% | +41.33% |
| Aug 28, 2026 | $20.84 | +7.15% | $2.30 | -36.99% | +44.14% |
| Aug 27, 2026 | $21.29 | +9.46% | $2.49 | -31.78% | +41.24% |
Page 1 of 5